Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Ronald Zolty. (2021) Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension. Journal of Experimental Pharmacology 13, pages 817-857.
Read now
Read now
Hongfei Xu, Hongyu Ji, Zerong Li, Wenmei Qiao, Chenghao Wang & Jingling Tang. (2021) In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery. International Journal of Nanomedicine 16, pages 1221-1229.
Read now
Read now
Shivshankar Thanigaimani, Dennis H Lau, Thomas Agbaedeng, Adrian D. Elliott, Rajiv Mahajan & Prashanthan Sanders. (2017) Molecular mechanisms of atrial fibrosis: implications for the clinic. Expert Review of Cardiovascular Therapy 15:4, pages 247-256.
Read now
Read now
Mayank Sardana, Matthew Moll & Harrison W Farber. (2015) Novel investigational therapies for treating pulmonary arterial hypertension. Expert Opinion on Investigational Drugs 24:12, pages 1571-1596.
Read now
Read now
Fabiana Baldi, Leonello Fuso, Eugenio Arrighi & Salvatore Valente. (2014) Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course. Therapeutics and Clinical Risk Management 10, pages 825-839.
Read now
Read now
Nicolas Hunzelmann. (2013) Developments into understanding the pathogenesis of systemic sclerosis. Expert Review of Dermatology 8:3, pages 267-276.
Read now
Read now
Simon Malenfant, Guillaume Margaillan, Jérémy Edwin Loehr, Sébastien Bonnet & Steeve Provencher. (2013) The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future. Expert Review of Respiratory Medicine 7:1, pages 43-55.
Read now
Read now
Rajamma Mathew. (2012) PDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal. Expert Opinion on Investigational Drugs 21:2, pages 139-142.
Read now
Read now
Articles from other publishers (45)
Yilin Xiong, Yan Wang, Tao Yang, Yunmei Luo, Shangfu Xu & Lisheng Li. (2023) Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells. American Journal of Cardiovascular Drugs.
Crossref
Crossref
Jiuliang Zhao, Qian Wang, Xiaoyue Deng, Junyan Qian, Zhuang Tian, Yongtai Liu, Mengtao Li & Xiaofeng Zeng. (2022) The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future. Pharmacology & Therapeutics 239, pages 108192.
Crossref
Crossref
Aleksandra Babicheva, Ayako Makino & Jason X.-J. Yuan. (2021) mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target. International Journal of Molecular Sciences 22:4, pages 2144.
Crossref
Crossref
Jiayi Yin, Xiaoxu Li, Fengcheng Li, Yinjing Lu, Su Zeng & Feng Zhu. (2021) Identification of the key target profiles underlying the drugs of narrow therapeutic index for treating cancer and cardiovascular disease. Computational and Structural Biotechnology Journal 19, pages 2318-2328.
Crossref
Crossref
Mehreen Batool, Eva M. Berghausen, Mario Zierden, Marius Vantler, Ralph T. Schermuly, Stephan Baldus, Stephan Rosenkranz & Henrik ten Freyhaus. (2020) The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice. Basic Research in Cardiology 115:6.
Crossref
Crossref
Ronald Zolty. (2020) Pulmonary arterial hypertension specific therapy: The old and the new. Pharmacology & Therapeutics 214, pages 107576.
Crossref
Crossref
Kang Wu, Haiyang Tang, Ruizhu Lin, Shane G. Carr, Ziyi Wang, Aleksandra Babicheva, Ramon J. Ayon, Pritesh P. Jain, Mingmei Xiong, Marisela Rodriguez, Shamin Rahimi, Francesca Balistrieri, Shayan Rahimi, Daniela Valdez‐Jasso, Tatum S. Simonson, Ankit A. Desai, Joe G.N. Garcia, John Y.‐J. Shyy, Patricia A. Thistlethwaite, Jian Wang, Ayako Makino & Jason X.‐J. Yuan. (2020) Endothelial platelet‐derived growth factor‐mediated activation of smooth muscle platelet‐derived growth factor receptors in pulmonary arterial hypertension. Pulmonary Circulation 10:3, pages 1-15.
Crossref
Crossref
Chiharu Morii, Hiroyoshi Y. Tanaka, Yasuhisa Izushi, Natsumi Nakao, Masaya Yamamoto, Hiromi Matsubara, Mitsunobu R. Kano & Aiko Ogawa. (2020) 3D in vitro Model of Vascular Medial Thickening in Pulmonary Arterial Hypertension. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Annette D. Rieg, Nina A. Bünting, Christian Cranen, Said Suleiman, Jan W. Spillner, Heike Schnöring, Thomas Schröder, Saskia von Stillfried, Till Braunschweig, Paul W. Manley, Gereon Schälte, Rolf Rossaint, Stefan Uhlig & Christian Martin. (2019) Tyrosine kinase inhibitors relax pulmonary arteries in human and murine precision-cut lung slices. Respiratory Research 20:1.
Crossref
Crossref
Junhui Xing, Mengyu Wang, Jin Hong, Yueqiao Gao, Yuzhou Liu, Heping Gu, Jianzeng Dong & Ling Li. (2019) TRPM7 channel inhibition exacerbates pulmonary arterial hypertension through MEK/ERK pathway. Aging 11:12, pages 4050-4065.
Crossref
Crossref
Annette D. Rieg, Said Suleiman, Carolin Anker, Eva Verjans, Rolf Rossaint, Stefan Uhlig & Christian Martin. (2018) PDGF-BB regulates the pulmonary vascular tone: impact of prostaglandins, calcium, MAPK- and PI3K/AKT/mTOR signalling and actin polymerisation in pulmonary veins of guinea pigs. Respiratory Research 19:1.
Crossref
Crossref
C.‐H. Heldin, J. Lennartsson & B. Westermark. (2017) Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis. Journal of Internal Medicine 283:1, pages 16-44.
Crossref
Crossref
Dale D. Tang. 2018. Vascular Pharmacology: Cytoskeleton and Extracellular Matrix. Vascular Pharmacology: Cytoskeleton and Extracellular Matrix
1
38
.
Dale D. Tang & Brennan D. Gerlach. (2017) The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration. Respiratory Research 18:1.
Crossref
Crossref
Iva Gudernova, Silvie Foldynova-Trantirkova, Barbora El Ghannamova, Bohumil Fafilek, Miroslav Varecha, Lukas Balek, Eva Hruba, Lucie Jonatova, Iva Jelinkova, Michaela Kunova Bosakova, Lukas Trantirek, Jiri Mayer & Pavel Krejci. (2017) One reporter for in-cell activity profiling of majority of protein kinase oncogenes. eLife 6.
Crossref
Crossref
Giuseppe Tridente. 2017. Adverse Events and Oncotargeted Kinase Inhibitors. Adverse Events and Oncotargeted Kinase Inhibitors
97
122
.
Jia Li, Ruping Wang & Dale D. Tang. (2016) Vimentin dephosphorylation at ser-56 is regulated by type 1 protein phosphatase in smooth muscle. Respiratory Research 17:1.
Crossref
Crossref
Kazuyuki Tsujino & Dean Sheppard. (2015) Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma. Current Rheumatology Reports 18:1.
Crossref
Crossref
Oren Pasvolsky, Avi Leader, Zaza Iakobishvili, Yishay Wasserstrum, Ran Kornowski & Pia Raanani. (2015) Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardio-Oncology 1:1.
Crossref
Crossref
Dale D. Tang. (2015) Critical role of actin-associated proteins in smooth muscle contraction, cell proliferation, airway hyperresponsiveness and airway remodeling. Respiratory Research 16:1.
Crossref
Crossref
Yoshihide Asano & Shinichi Sato. (2015) Vasculopathy in scleroderma. Seminars in Immunopathology 37:5, pages 489-500.
Crossref
Crossref
Didier Renard, Thomas Bouillon, Ping Zhou, Gerard Flesch & Debbie Quinn. (2015) Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension. British Journal of Clinical Pharmacology 80:1, pages 75-85.
Crossref
Crossref
Henrik ten FreyhausEva M. BerghausenWiebke JanssenMaike LeuchsMario ZierdenKirsten MurmannAnna KlinkeMarius VantlerEvren CaglayanTilmann KramerStephan BaldusRalph T. SchermulyMichelle D. TallquistStephan Rosenkranz. (2015) Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology 35:5, pages 1236-1245.
Crossref
Crossref
Stephan Rosenkranz. (2014) Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options. Clinical Research in Cardiology 104:3, pages 197-207.
Crossref
Crossref
Andrea OlschewskiEdward Kenneth Weir. (2015) Redox Regulation of Ion Channels in the Pulmonary Circulation. Antioxidants & Redox Signaling 22:6, pages 465-485.
Crossref
Crossref
Mala Sharma, Sowmya Pinnamaneni, Wilbert S. Aronow, Bartosz Jozwik & William H. Frishman. (2014) Existing Drugs and Agents Under Investigation for Pulmonary Arterial Hypertension. Cardiology in Review 22:6, pages 297-305.
Crossref
Crossref
Neil McGlinchey & Martin K Johnson. (2014) Novel serum biomarkers in pulmonary arterial hypertension. Biomarkers in Medicine 8:8, pages 1001-1011.
Crossref
Crossref
Magdalena Jasińska-Stroschein & Daria Orszulak-Michalak. (2014) The current approach into signaling pathways in pulmonary arterial hypertension and their implication in novel therapeutic strategies. Pharmacological Reports 66:4, pages 552-564.
Crossref
Crossref
Carl-Henrik Heldin. (2013) Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases. Journal of Neuroimmune Pharmacology 9:2, pages 69-79.
Crossref
Crossref
P. Boor, T. Ostendorf & J. Floege. (2014) PDGF and the progression of renal disease. Nephrology Dialysis Transplantation 29:suppl 1, pages i45-i54.
Crossref
Crossref
S. Rosenkranz. (2014) Cor pulmonale und pulmonale HypertonieCor pulmonale and pulmonary hypertension. Herz 39:1, pages 58-65.
Crossref
Crossref
T Hoehler, G von Wichert, C Schimanski, S Kanzler, M H Moehler, A Hinke, T Seufferlein, J Siebler, A Hochhaus, D Arnold, M Hallek, R Hofheinz & U T Hacker. (2013) Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205. British Journal of Cancer 109:6, pages 1408-1413.
Crossref
Crossref
Christina L. Papke, Jiumei Cao, Callie S. Kwartler, Carlos Villamizar, Katerina L. Byanova, Soon-Mi Lim, Harini Sreenivasappa, Grant Fischer, John Pham, Meredith Rees, Miranda Wang, Christine Chaponnier, Giulio Gabbiani, Aarif Y. Khakoo, Joya Chandra, Andreea Trache, Warren Zimmer & Dianna M. Milewicz. (2013) Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β. Human Molecular Genetics 22:15, pages 3123-3137.
Crossref
Crossref
Tao Wang, Rachel A. Cleary, Ruping Wang & Dale D. Tang. (2013) Role of the Adapter Protein Abi1 in Actin-associated Signaling and Smooth Muscle Contraction. Journal of Biological Chemistry 288:28, pages 20713-20722.
Crossref
Crossref
Joel Rosenbloom, Fabian A. Mendoza & Sergio A. Jimenez. (2013) Strategies for anti-fibrotic therapies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1832:7, pages 1088-1103.
Crossref
Crossref
Anupama Shahane. (2013) Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis. Rheumatology International 33:7, pages 1655-1667.
Crossref
Crossref
Rashmi R. Shah, Joel Morganroth & Devron R. Shah. (2013) Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval). Drug Safety 36:5, pages 295-316.
Crossref
Crossref
Simon Malenfant, Anne‐Sophie Neyron, Roxane Paulin, François Potus, Jolyane Meloche, Steeve Provencher & Sébastien Bonnet. (2013) Signal Transduction in the Development of Pulmonary Arterial Hypertension. Pulmonary Circulation 3:2, pages 278-293.
Crossref
Crossref
Alexander Gise, Stephen L. Archer, Margaret R. MacLean & Georg Hansmann. (2013) The First Keystone Symposia Conference on Pulmonary Vascular Disease and Right Ventricular Dysfunction: Current Concepts and Future Therapies. Pulmonary Circulation 3:2, pages 275-277.
Crossref
Crossref
Rajeev Malhotra, Samuel Paskin‐Flerlage, Roham T. Zamanian, Patrick Zimmerman, Jonathan W. Schmidt, Donna Y. Deng, Mark Southwood, Robert Spencer, Carol S. Lai, William Parker, Richard N. Channick, Nicholas W. Morrell, C. Gregory Elliott & Paul B. Yu. (2013) Circulating Angiogenic Modulatory Factors Predict Survival and Functional Class in Pulmonary Arterial Hypertension. Pulmonary Circulation 3:2, pages 369-380.
Crossref
Crossref
Vijaya KaroorMasahiko OkaSandra J. WalchakLouis B. HershYork E MillerEdward C. Dempsey. (2013) Neprilysin Regulates Pulmonary Artery Smooth Muscle Cell Phenotype Through a Platelet-Derived Growth Factor Receptor–Dependent Mechanism. Hypertension 61:4, pages 921-930.
Crossref
Crossref
Loredana Ciuclan, Martin J. Hussey, Victoria Burton, Robert Good, Nicholas Duggan, Sarah Beach, Peter Jones, Roy Fox, Ieuan Clay, Olivier Bonneau, Irena Konstantinova, Andrew Pearce, David J. Rowlands, Gabor Jarai, John Westwick, Margaret R. MacLean & Matthew Thomas. (2013) Imatinib Attenuates Hypoxia-induced Pulmonary Arterial Hypertension Pathology via Reduction in 5-Hydroxytryptamine through Inhibition of Tryptophan Hydroxylase 1 Expression. American Journal of Respiratory and Critical Care Medicine 187:1, pages 78-89.
Crossref
Crossref
Patrick Y. Muller & Mark N. Milton. (2012) The determination and interpretation of the therapeutic index in drug development. Nature Reviews Drug Discovery 11:10, pages 751-761.
Crossref
Crossref
Ya-Ting ChangAndreas Ringman Uggla, Cecilia ÖsterholmPhan-Kiet Tran, Ann-Christine Eklöf, Mariette LengquistUlf HedinKarin Tran-LundmarkBjörn Frenckner. (2012) Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia. American Journal of Physiology-Lung Cellular and Molecular Physiology 302:11, pages L1159-L1166.
Crossref
Crossref
Maria A. CavasinKim Demos-DaviesTodd R. HornLori A. WalkerDouglas D. LemonNicholas BirdseyMary C.M. Weiser-EvansJulie HarralDavid C. IrwinAdil AnwarMichael E. YeagerMin LiPeter A. WatsonRaphael A. NemenoffPeter M. ButtrickKurt R. StenmarkTimothy A. McKinsey. (2012) Selective Class I Histone Deacetylase Inhibition Suppresses Hypoxia-Induced Cardiopulmonary Remodeling Through an Antiproliferative Mechanism. Circulation Research 110:5, pages 739-748.
Crossref
Crossref